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Purpose: The cause of the coagulopathy seen with supraceliac aortic cross-clamping (SC AXC) is unclear. SC AXC for 30
minutes results in both clotting factor consumption and activation of fibrinolytic pathways. This study was undertaken
to define the hemostatic alterations that occur with longer intervals of SC AXC.
Methods: Seven pigs underwent SC AXC for 60 minutes. Five pigs that underwent infrarenal aortic cross-clamping (IR
AXC) for 60 minutes and 11 pigs that underwent SC AXC for 30 minutes served as controls. No heparin was used. Blood
samples were drawn at baseline, 5 minutes before release of the aortic clamp, and 5, 30, and 60 minutes after unclamping.
Prothrombin time, partial thromboplastin time, platelet count, and fibrinogen concentration were measured as basic tests
of hemostatic function. Thrombin-antithrombin complexes were used to detect the presence of intravascular thrombosis.
Fibrinolytic pathway activation was assessed with levels of tissue plasminogen activator antigen and tissue plasminogen
activator activity, plasminogen activator inhibitor-1 activity, and 2-antiplasmin activity. Statistical analysis was
performed with the Student t test and repeated measures of analysis of variance.
Results: Prothrombin time, partial thromboplastin time, and platelet count did not differ between groups at any time.
Fibrinogen concentration decreased 5 minutes (P  .005) and 30 minutes (P  .006) after unclamping in both SC AXC
groups, but did not change in the IR AXC group. Thrombin-antithrombin complexes increased in both SC AXC groups,
but were not significantly greater than in the IR AXC group. SC AXC for both 30 and 60 minutes produced a significant
increase in tissue plasminogen activator antigen during clamping and 5 minutes after clamping. This increase persisted for
30 and 60 minutes after clamp release in the 60-minute SC AXC group. Tissue plasminogen activator activity, however,
increased only in the 60-min SC AXC group during clamping (P  .02), and 5 minutes (P  .05) and 30 minutes (P 
.06) after unclamping, compared with both control groups.
Conclusions: Thirty and 60 minutes of SC AXC results in similar degrees of intravascular thrombosis and fibrinogen
depletion. Although SC AXC for both 30 and 60 minutes leads to activation of fibrinolytic pathways, only 60 minutes of
SC AXC actually induces a fibrinolytic state. Fibrinolysis appears to be an important component of the coagulopathy
associated with SC AXC, and is related to the duration of aortic clamping. (J Vasc Surg 2004;40:325-33.)
Clinical Relevance: The coagulopathy frequently associated with thoracoabdominal aortic aneurysm repair is thought to
revolt visceral ischemia-reperfusion. The nature of this coagulopathy is controversial. The current study demonstrates
that the major hemostatic alteration associated with supraceliac aortic cross-clamping is activation of fibrinolytic
pathways. The magnitude of this fibrinolytic response is directly related to the duration of supraceliac aortic occlusion.
Future efforts to treat this coagulopathy may well include judicious use of autofibrinolytic agents.Aortic cross-clamping proximal to the celiac trunk is
frequently necessary during complex procedures on the
thoracoabdominal aorta. Excessive bleeding is common
during these procedures, and can be a source of significant
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doi:10.1016/j.jvs.2004.04.015morbidity and mortality. As many as 25% of early deaths
after thoracoabdominal aneurysm (TAAA) repair result
from bleeding complications.1,2 Bleeding is also thought to
be a significant contributor to multisystem organ dysfunc-
tion, which is the most common cause of perioperative
death after TAAA repair. In most cases this bleeding is the
result of a diffuse coagulopathy that is thought to be related
to visceral ischemia-reperfusion.3-5
The nature of this coagulopathy is unclear, and there
are only limited studies in the literature. In the late 1980s
Cohen et al3 suggested that the cause was disseminated
intravascular coagulation (DIC). Using a canine model,
they showed that 60 and 90 minutes of supraceliac aortic
cross-clamping (SC AXC) was associated with a decrease in
platelet count and fibrinogen concentration, and prolonga-325
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time (PTT).3 These hemostatic alterations were prevented
with continuous arterial perfusion of the superior mesen-
teric artery (SMA) during prolonged cross-clamping.4 This
work has been criticized because of lack of specificity of the
studies used to document DIC. Nearly a decade later, Illig
et al5 published a study that suggested that SC AXC in-
duces primary fibrinolysis. Using a population of patients
undergoing elective aortic reconstruction, they demon-
strated elevated levels of tissue plasminogen activator (t-
PA) and reduced levels of 2-antiplasmin (2-AP) in pa-
tients undergoing SC AXC. However, only t-PA antigen
(t-PA Ag) was measured in this study, and not t-PA activity;
recent data have proved that elevated t-PA Ag levels alone
can be misleading in determining the presence of fibrino-
lysis, because t-PA Ag reflects both active and inactive
forms of t-PA.6-8
Previous work in our laboratory has demonstrated that
SC AXC for 30 minutes results in both intravascular throm-
bosis with factor (primarily fibrinogen) consumption and
activation of fibrinolytic pathways.9,10 Although SC AXC
for 30 minutes did activate fibrinolysis, as determined by a
marked increase in t-PA Ag, it did not induce a fibrinolytic
state; t-PA activity levels remained normal. The current
study was undertaken to determine whether longer inter-
vals of supraceliac aortic occlusion would lead to more
pronounced factor consumption, more significant fibrino-
lysis, or both.
METHODS
Market pigs weighing 25 to 35 kg were used for the
study. A porcine model was chosen because of the known
similarities of its coagulation physiology with that in human
beings.11,12 Pigs were tested for von Willebrand disease
before selection for study. Animals were sedated, and un-
derwent general endotracheal anesthesia with 1% to 2%
isoflurane. A right neck cutdown was performed for place-
ment of monitoring and sampling catheters. A pulmonary
artery catheter was placed through the jugular vein and
advanced under fluoroscopy into the correct position. This
catheter was used to ensure optimal hemodynamics during
the experiment. An arterial line was placed in the carotid
artery. Warming blankets and warmed intravenous fluids
were used to maintain normothermia. Lactated Ringer
solution was infused at a rate of 5 to 10 mL/kg/hr to keep
the animals hydrated. Intermittent boluses were used as
necessary to maintain hemodynamic stability. Other mon-
itoring included pulse oximetry and continuous electrocar-
diography.
Each pig underwent a midline celiotomy. Before dis-
section, a Foley catheter was inserted into the bladder to
help in monitoring volume status. The aorta was then
dissected and controlled above the celiac trunk, just below
the renal arteries and above the aortic trifurcation. During
aortic clamping the aorta was occluded proximally at the
designated clamp site and distally just above the trifurca-
tion. Seven pigs underwent SC AXC for 60 minutes. Con-
trol groups consisted of 5 pigs that underwent infrarenalaortic cross-clamping (IR AXC) for 60 minutes and 11 pigs
that underwent SC AXC for 30 minutes. After unclamping,
the animals were observed for 1 hour. No heparin was used.
Blood samples were obtained from the arterial line before
cross-clamping as baseline measurements, 5 minutes before
cross-clamp release, and 5, 30, and 60 minutes after cross-
clamp release. Blood samples were immediately transported
to the hematopathology laboratory for processing. After
the last blood sample was drawn, animals were sacrificed
according to institutional protocol.
Blood samples were collected in tubes containing 0.5
mL of 0.5 mol/L citrate buffer, pH 4.3 (Stabilyte; Biopool
International), 0.5 mL of 0.11 mol/L sodium citrate (BD
Vacutainer), and 15% (K3) ethylenediamine tetra-acetic
acid (BD Vacutainer). Plasma was isolated within 30 to 60
minutes by means of centrifugation at 1500 g for 15
minutes, aliquoted, and frozen at 30°C. Before freezing
the citrated aliquots for the specialized assays, samples were
screened for basic coagulation tests including PT, PTT, and
fibrinogen concentration. Platelet count and hematocrit
were determined with a Coulter AcT8 (Coulter Corp). The
sodium- citrated samples were used to measure thrombin-
antithrombin complexes (TAT) with the Enzygnost TAT
microenzyme immunoassay (Dade Behring). An enzyme-
linked immunosorbent assay (TintElize t-PA; Biopool In-
ternational) was used for quantitative determination of
t-PA Ag. Assessment of t-PA activity and plasminogen
activator inhibitor-1 activity (PAI-1) was accomplished
with a chromogenic assay (Spectrolyze/fibrin; Biopool In-
ternational). 2-AP activity was measured with the STA-
Stachrom Antiplasmin chromogenic assay (Diagnostica
Stago).
All results are expressed as mean  SEM. A repeated
measures analysis of variance (ANOVA) model was used to
test for any significant differences over time in each of the
three groups. When there were statistically significant over-
all time differences (P  .05), pairwise comparisons were
used to determine where the significant time differences
were via paired testing. When significant group by time
interactions were observed, the Student t test was per-
formed to look for differences at each time point between
groups. For all pairwise comparisons, the Hochberg
method was used to adjust P values for multiple compari-
sons. The package used for statistical analysis was SAS (SAS
Institute Inc).
This experiment was approved by the Henry Ford
Hospital Care of Experimental Animals Committee, and
conformed with the Guide for the Care and Use of Labora-
tory Animals.
RESULTS
A summary of the data analysis from this study is
presented in the Table.
Basic coagulation test. There was no significant
change in PTT or platelet count from baseline in any of the
study groups. PT was prolonged in the 30- minute SC AXC
group just after unclamping (P  .005), and remained
prolonged 30 and 60 minutes after unclamping (P .005,
p (IR
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two groups at t testing, these changes were not significant.
There was a significant decrease in fibrinogen concen-
tration (corrected for dilution) in both the 30-minute (P
.001, ANOVA) and 60-minute (P  .001, ANOVA) SC
AXC groups (Fig 2). This decrease began just after un-
clamping, and continued throughout the remainder of the
experiment in both groups. The decrease in fibrinogen
concentration was greater in the 60-minute SC AXC group
compared with the 30-minute SC AXC group (P  .03)
only at 5 minutes after unclamping. There was no change in
fibrinogen concentration in the IR AXC group.
Fig 1. Prothrombin time (PT) in the 30- minute and 60
and the 60-minute infrarenal aortic cross clamping grou
Fig 2. Fibrinogen (FBG) levels in the 30-minute and 60
and the 60-minute infrarenal aortic cross clamping gro
dilution with hematocrit (HCT).Markers of thrombosis. TAT complexes increased in
both SC AXC groups during the period of aortic clamping,
and returned to baseline after clamp release; however, these
changes did not reach statistical significance (P  .18; Fig
3). There was no change in TAT levels from baseline in the
IR AXC group.
Markers of fibrinolysis. There was a significant in-
crease in t-PA Ag levels during the period of aortic clamp-
ing in both SC AXC groups (P  .001, ANOVA; Fig 4).
t-PA Ag levels remained significantly elevated 30 and 60
minutes after clamp release (P  .034) with 60 minutes of
SC AXC. In the 30-minute SC AXC group t-PA Ag levels
ute supraceliac aortic cross-clamping groups (SC AXC)
AXC).
ute supraceliac aortic cross-clamping groups (SC AXC)
R AXC). Fibrinogen concentration was corrected for-min-min
up (I
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change in t-PA Ag levels in the IR AXC group at any time
point.
To determine whether this increase in t-PA Ag was
associated with a fibrinolytic state, t-PA activity was also
measured. In the 60-minute SC AXC group, t-PA activity
increased during the period of aortic occlusion, remained
elevated 5 minutes after clamp release (P  .012), and
decreased toward baseline by 30 minutes after unclamping
(Fig 5). There was no significant change in t-PA activity
from baseline in either the 30-minute SC AXC group or the
IR AXC group.
A non-significant decrease in PAI-1 levels occurred
in both SC AXC groups up to 30 minutes after clamp
release (Fig 6). By 60 minutes after unclamping, PAI-1
had increased above baseline in both SC AXC groups,
but this change was only significant in the 30-minute SC
AXC group (P  .001, ANOVA). In comparison with
the 60-minute SC AXC group, this rise was not signifi-
cant at t testing. There was no significant change in
PAI-1 levels in the IR AXC group. 2-AP activity levels
decreased from baseline 5 and 30 minutes after unclamp-
ing in both SC AXC groups (P  .01, ANOVA), but
returned toward baseline 60 minutes after cross-clamp
release (Fig 7). There was no significant change in the IR
group.
Data analysis ( from baseline)
PTT PL
Mean  SD P Mean  SD
60-Min SC AXC
5 Min before
unclamping
–0.67  3.50 .29 –0.52  0.51
5 Min after
unclamping
–0.83  2.14 .29 1.38  4.27
30 Min after
unclamping
0.00  2.97 .29 1.09  4.46
60 Min after
unclamping
–1.83  3.31 .29 0.88  4.92
30-Min SC AXC
5 Min before
unclamping
0.60  2.91 .12 1.28  0.41
5 Min after
unclamping
1.70  3.37 .12 0.94  0.3
30 Min after
unclamping
2.80  3.29 .12 1.35  0.43
60 Min after
unclamping
1.00  2.83 .12 1.16  0.37
60-Min IR AXC
5 Min before
unclamping
–0.60  0.55 .72 4.43  2.56
5 Min after
unclamping
–0.60  1.14 .72 4.28  2.47
30 Min after
unclamping
0.00  3.16 .72 4.00  2.31
60 Min after
unclamping
–0.40  2.51 .72 4.05  2.34
SC AXC, Supraceliac aortic cross-clamping; IR AXC, infrarenal aortic crosDISCUSSION
The nature of the coagulopathy associated with SC
AXC remains controversial. While most authorities agree
that intravascular thrombosis with factor consumption or
depletion, so called DIC, has an important role,3,4,13 oth-
ers believe that fibrinolysis is the major culprit.2,5 The
evidence that fibrinolysis occurs with SC AXC is limited. In
a series of 33 patients undergoing TAAA repair Godet et al2
noted severe bleeding complications in 8 patients; these
patients had significantly higher levels of t-PA and lower
levels of 2-AP both during the period of SC AXC and
shortly after restoration of visceral perfusion, compared
with the 25 patients who did not bleed. Illig et al5 demon-
strated similar changes in a group of patients undergoing
elective abdominal aortic reconstruction. A previous study
from our laboratory documented the presence of both
factor consumption and increased t-PA Ag levels with 30
minutes of supraceliac aortic occlusion. t-PA activity, how-
ever, did not increase, which suggests that normal regula-
tory mechanisms (PAI-1 inactivation, hepatic clearance) are
capable of controlling the fibrinolytic pathway activation
resulting from SC AXC for 30 minutes.9 The current study
was designed to document the hemostatic alterations that
occur with longer durations of supraceliac aortic occlusion.
SC AXC for both 30 and 60 minutes led to significant
fibrinogen depletion in this study. The cause of this deple-
PT FBG
P Mean  SD P Mean  SD P
.73 –0.13  0.45 .06 –0.35  0.53 .05
.73 –0.08  0.38 .06 –0.43  2.44 .01
.73 0.42  0.47 .06 –0.75  2.13 .01
.73 0.50  0.46 .06 –0.66  2.10 .01
.05 0.18  0.58 .05 –0.19  0.36 .05
.05 1.02  0.52 .01 –0.87  0.38 .01
.05 1.38  1.36 .01 –1.01  0.37 .01
.05 1.15  0.89 .01 –1.12  0.87 .01
.06 0.16  0.27 .44 2.3  2.28 .05
.06 0.26  0.46 .44 2.1  2.08 .05
.06 0.38  0.79 .44 2.1  2.07 .05
.06 0.46  0.82 .44 2.1  2.03 .05
ping.T
s-clam
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resulting from clamp-induced intravascular thrombosis. El-
evations of TAT in these two groups compared with the IR
AXC group lend support to the theory that SC AXC is
associated with a greater microvascular clot burden. Efforts
to study this point further were hampered by the absence of
accurate assays for porcine D-dimers and other coagulation
factors. The lack of significant changes in PT, PTT, or
platelet count suggests that this factor consumption was
not enough to substantially perturb normal clotting func-
tion. In our previous study SC AXC for 30 minutes was
associated with a small but significant decrease in platelet
count and an increase in PTT 30 minutes after unclamp-
ing.9 Our failure to confirm these findings in the current
study is unexplained.
In this study SC AXC resulted in activation of fibrino-
lytic pathways, the intensity of which was directly related to
the duration of aortic occlusion. Clamping for 30 minutes
led to a significant increase in t-PA Ag, which fell rapidly
back to baseline after unclamping. In contrast, supraceliac
occlusion for 60 minutes led to markedly elevated levels of
t-PA Ag during clamping, which persisted for up to 60
minutes after unclamping. Similar to our previous study,
the elevation in t-PA Ag in the 30-minute group was not
associated with an increase in t-PA activity. However, the
more pronounced elevations in t-PA Ag in the 60-minute
group were associated with marked increases in t-PA activ-
(Table continued)
TAT t-PA Ag t-
Mean  SD P Mean  SD P Mean 
11.43  17.81 .18 9.17  5.36 .03 37.38 
14.90  20.67 .18 9.37  8.50 .05 32.25 
13.50  19.94 .18 8.08  4.91 .03 15.92 
10.60  21.14 .18 6.15  3.51 .03 0.10 
25.04  39.05 .16 6.13  2.90 .01 8.99 
30.01  44.13 .16 3.26  1.80 .05 9.86 
5.75  22.22 .16 0.92  2.07 .05 –3.71 
8.04  13.12 .16 –.22  1.49 .05 –4.06 
–1.84  8.66 .24 –0.64  1.15 .27 –4.12 
–2.04  12.98 .24 –0.04  1.11 .27 –10.52 
–9.16  6.25 .24 –0.64  1.14 .27 –10.34 
–3.30  7.09 .24 –0.34  1.13 .27 –9.12 ity both during and immediately after the period of aortic
occlusion. The changes in PAI-1 (the major circulating
inhibitor of t-PA) and 2-AP (the major inhibitor of plas-
min) activity levels in the SC AXC groups provide confir-
matory evidence for stimulation of fibrinolytic pathways. In
our study, PAI-1 activity did drop during the period of
aortic occlusion in both SC AXC groups, and remained
depressed for up to 30 minutes after unclamping, com-
pared with the IR AXC group, in which it actually in-
creased. Although none of these changes were statistically
significant, the trend toward lower PAI-1 levels in the SC
AXC groups is probably in response to increased t-PA
generation. Similarly, 2-AP activity levels also decreased in
both SC AXC groups after unclamping, but remained
unchanged in the IR AXC group, no doubt in response to
increased plasmin generation from increased t-PA release.
These changes reflect activation of serum inhibitors de-
signed to hold the fibrinolytic system in check.
Both t-PA Ag and t-PA activity were measured because
recent data show that t-PA Ag alone is not an accurate
measure of the presence of fibrinolysis. t-PA Ag detects
both active (free t-PA) and inactive (bound by serum
inhibitors) forms of t-PA, and is thus a marker only for
activation of fibrinolytic pathways. t-PA activity, on the
other hand, detects only free t-PA, and is thus a more
accurate measure of whether a true fibrinolytic state is
present.6-8
ct PAI-1 2-AP
P Mean  SD P Mean  SD P
.01 –1.43  5.29 .11 0.17  10.61 .05
.01 –4.33  5.06 .11 –17.33  8.57 .01
.05 –0.13  8.21 .11 –16.83  7.0 .01
.05 6.65  9.38 .11 –10.33  14.36 .05
.94 –2.16  5.83 .05 –4.00  6.06 .05
.94 –4.69  6.62 .05 –16.00  4.03 .04
.94 –4.11  5.03 .05 –17.3  8.39 .04
.94 4.00  6.49 .05 –10.1  14.71 .05
.17 10.24  7.88 .15 –2.8  4.09 .09
.17 7.98  13.06 .15 –8.4  7.54 .09
.17 9.12  11.29 .15 –9.00  5.39 .09
.17 11.08  13.65 .15 –6.6  9.34 .09PA a
SD
29.60
20.54
20.04
4.37
14.72
20.17
5.31
8.09
16.74
11.31
10.71
9.67
ross c
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degree of fibrinolytic pathway activation. In this study, IR
AXC was associated with no change in t-PA activity, t-PA
Ag, or their plasma inhibitors. These findings point to the
importance of the liver in regulating the fibrinolytic system.
First-pass hepatic clearance of t-PA is as important as serum
inhibitors in controlling t-PA activity.6 SC AXC markedly
reduces hepatic perfusion and eliminates this regulatory
pathway. In addition, because the liver is a major site for
PAI-1 production, hepatic ischemia can also potentially
reduce the pool of available serum inhibitors. Illig et al5
likened the changes attendant with SC AXC to those oc-
curring during the anhepatic phase of liver transplantation.
Fig 3. Thrombin-antithrombin complexes (TAT) in the
groups (SC AXC) and the 60-minute infrarenal aortic c
Fig 4. Tissue plasminogen activator antigen (t-PA Ag
clamping groups (SC AXC) and the 60-minute infrarenIn this setting, enhanced t-PA release and decreased hepatic
clearance lead to bleeding complications from unregulated
fibrinolysis.14 The importance of reduced hepatic clearance
has been highlighted in studies that compared heterotopic
with orthotopic liver transplantation. Elevated t-PA levels
common to orthotopic transplantation are not found with
heterotopic transplantation when the host liver is not re-
moved.15 The results of the current study suggest that
PAI-1 and other serum inhibitors are adequate to hold the
fibrinolytic system in check with supraceliac occlusion of
short duration (30 minutes); however, with longer peri-
ods of SC AXC these compensatory mechanisms are over-
whelmed, leading to the presence of a fibrinolytic state.
inute and 60-minute supraceliac aortic cross-clamping
lamping group (IR AXC).
he 30-minute and 60-minute supraceliac aortic cross-
tic cross clamping group (IR AXC).30-m) in t
al aor
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t-PA release is not clear. Two possibilities seem likely. The
first is that t-PA release occurs with induction of tissue
ischemia. Schneiderman et al16,17 documented that acute
ischemia leads to a rapid rise in t-PA activity resulting from
the release of stored t-PA in ischemic tissue beds. In addi-
tion, they also demonstrated that acute ischemia can in-
crease t-PA gene expression in distant well-perfused tissues,
which suggests that non-ischemic tissues may be induced to
Fig 5. Tissue plasminogen activator activity (t-PA act
clamping groups (SC AXC) and the 60-minute infraren
Fig 6. Plasminogen activator inhibitor activity (PAI-1
cross-clamping groups (SC AXC) and the 60-minute inproduce more sustained t-PA levels by humoral mediators
released from the ischemic site.17 The more proximal the
site of aortic occlusion and the longer the duration of
clamping, the larger the ischemic tissue burden and the
greater the production of t-PA. The second possibility is
that the presence of intravascular clot leads to an appropri-
ate and protective activation of the fibrinolytic system.
So-called secondary fibrinolysis is believed to be the cause
of the fibrinolytic changes seen with DIC.18,19 Which
he 30-minute and 60-minute supraceliac aortic cross-
tic cross clamping group (IR AXC).
he 30-minute (min) and 60-minute supraceliac aortic
al aortic cross clamping group (IR AXC).) in t) in t
fraren
g gro
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role in the activation of fibrinolytic pathways with SC AXC.
Measurement of D-dimers would have been helpful to
answer the question; elevated D-dimers would be expected
in the presence of intravascular thrombus. Currently avail-
able assays for D-dimers do not have good porcine reactiv-
ity. Regardless of cause, t-PA Ag levels rise dramatically
with SC AXC in a time-dependent manner.
There are several limitations to this study. A larger
sample size would assist in determining whether the trends
associated with the various measured factors, such as TAT,
PAI-1, or 2-AP, were significant. With the current sample
size we only had enough power to detect fairly large differ-
ences, as in t-PA activity. Even though there were no
obvious bleeding abnormalities with these experiments,
this was difficult to quantify. In addition, we used a porcine
model to conduct the experiments. The advantage of this
model is that the proteins and biochemical factors are not
greatly different from those in human beings. In terms of
coagulation parameters, factors I, II, XI, XIII, fibrinogen,
antithrombin III, TAT, t-PA, PAI-1, and protein C are
present at levels near those in human beings. Pigs have
higher levels of factors V, VII, VIII, IX, X, and XII than in
human beings. Also, D-dimers do not have good porcine
reactivity.12 Despite these limitations for this model, we
believe it is adequate to examine hemostatic modifications.
Whether the fibrinolytic pathway activation demon-
strated in this study is a primary or secondary phenomenon,
the major cause would appear to be visceral ischemia-
reperfusion. Svensson et al20 recognized the importance of
minimizing visceral clamp times in the prevention of bleed-
ing complications with TAAA repair. In the late 1980s
Fig 7. 2-Antiplasmin activity (2-AP) in the 30-minut
AXC) and the 60-minute infrarenal aortic cross clampinCohen et al4 documented in a canine model that continu-
ous arterial perfusion of the SMA prevented the hemostatic
alterations associated with SC AXC. More recently Cam-
bria et al21 suggested that in-line shunting to the celiac
trunk or SMA during TAAA can reduce coagulopathic
bleeding complications. We have had some anecdotal suc-
cess with continuous cold perfusion of the SMA during
TAAA repair (similar to the cold renal artery perfusion used
for preservation of renal function20,21) in reducing the
requirement for clotting factors. Regardless of the method
used (shortening clamp times, visceral artery perfusion),
efforts to minimize the magnitude of visceral ischemia-
reperfusion should help to avert the hemostatic aberrations
seen with SC AXC. The current data also support the
possibility that antifibrinolytic agents, as suggested by Illig
et al5 and discounted by us,9 may be helpful in treating this
coagulopathy.
In conclusion, our data demonstrate that SC AXC
results in both intravascular thrombosis and fibrinogen
consumption that is not seen with IR AXC. In addition, SC
AXC leads to activation of the fibrinolytic system in a
time-dependent manner. With short duration of clamping
(30 minutes), serum inhibitors can compensate and avert
induction of a fibrinolytic state. Longer periods (60 min-
utes) of supraceliac occlusion, however, result in a much
greater accumulation of t-PA, which overwhelms regula-
tory mechanisms and leads to a fibrinolytic state. Whether
fibrinolysis in this setting is a primary or secondary (to
intravascular thrombosis) phenomenon is unclear. While
SC AXC results in both fibrinogen consumption and t-PA
release, with longer periods of clamping fibrinolytic activa-
tion rather than factor consumption is the predominant
60-minute supraceliac aortic cross-clamping groups (SC
up (IR AXC).e and
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Volume 40, Number 2 Haithcock et al 333finding. This unregulated fibrinolytic state appears to be
the cause of the coagulopathy associated with SC AXC.
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